{"id":"W2062369750","doi":"10.1111/j.1477-2574.2012.00441.x","title":"Meta-analysis of Phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer","year":2012,"lang":"en","type":"review","venue":"HPB","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Gemcitabine; Medicine; Internal medicine; Hazard ratio; Meta-analysis; Confidence interval; Odds ratio; Pancreatic cancer; Placebo; Oncology; Randomized controlled trial; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01132825,0.002754898,0.01313572,0.001643236,0.000339663,0.001722616,0.001612308,0.001165903,0.00376595],"category_scores_gemma":[0.02003624,0.001066219,0.02433235,0.00291966,0.0004677271,0.001163228,0.001053104,0.002196983,0.0003179965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001511455,"about_ca_system_score_gemma":0.001412603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002478766,"about_ca_topic_score_gemma":0.006123504,"domain_scores_codex":[0.9931334,0.004483272,0.001167651,0.0005992833,0.0004372068,0.0001792134],"domain_scores_gemma":[0.9906976,0.007048584,0.00132669,0.0004318341,0.0003477247,0.0001475698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0146696,0.00003777269,0.00211769,0.08261887,0.8844335,0.00007477666,0.00003078184,0.0008922452,0.0003220965,0.0001316253,0.0007622994,0.01390868],"study_design_scores_gemma":[0.003694289,0.0004256275,0.002154423,0.002654106,0.9888304,0.00006626768,0.00002008156,0.0001865247,0.0001276984,0.0003501145,0.001473944,0.00001660514],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01244832,0.9843337,0.001407264,0.0002630447,0.0003118691,0.0002054997,0.000575875,0.00004554723,0.0004088799],"genre_scores_gemma":[0.3916364,0.5990724,0.004313683,0.001606538,0.0004461446,0.0005763967,0.001413619,0.00007789901,0.000857031],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01313572,"threshold_uncertainty_score":0.05991024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.323072457906405,"score_gpt":0.5175700520400595,"score_spread":0.1944975941336545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}